Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series.
Histopathology
; 81(2): 246-254, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35758203
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Carcinoma, Small Cell
/
Carcinoma, Neuroendocrine
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Histopathology
Year:
2022
Type:
Article
Affiliation country:
United States